Literature DB >> 15784967

Trafficking of adenosine A2A and dopamine D2 receptors.

Maria Torvinen1, Carla Torri, Andrea Tombesi, Daniel Marcellino, Stan Watson, Carmen Lluis, Rafael Franco, Kjell Fuxe, Luigi F Agnati.   

Abstract

An interaction between adenosine A2A and dopamine D2 receptors has been demonstrated previously. It is generally found that agonist treatment internalizes receptors, including A2A and D2, whereas less is known of the long-term effects involved in the agonist-mediated trafficking of A2A and D2 receptors. Furthermore, the possible influence of the antagonists on receptor trafficking is still undefined. The present studies focus on the long-term effects of A2A and D2 agonist and D2 antagonist treatments on both A2A and D2 receptor trafficking studied at three different time intervals--3, 15, and 24 h. In addition, with the fluorescence resonance energy transfer technique, formation of heteromeric A2A and D2 receptor complexes was shown in the cotransfected CHO cell line. Confocal microscopy analysis showed that a 3-h treatment with the D2 agonist induced coaggregation of A2A/D2 receptors. These A2A/D2 receptor coaggregates internalized after 15 h with a recruitment of the receptors back to the cell membrane after 24 h. In contrast to the effects of the agonist treatment, a 3-h treatment with the D2-like antagonist raclopride increased both A2A and D2 immunoreactivity, indicating that the D2 antagonist stabilizes the D2 receptor and thereby reduces the internalization of both of the A2A and D2 receptors. Taken together, an activation of either A2A and D2 receptor or blockade of D2 receptors will cause long-lasting changes in A2A and D2 receptor trafficking.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784967     DOI: 10.1385/JMN:25:2:191

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  22 in total

Review 1.  Oligomerization of G-protein-coupled transmitter receptors.

Authors:  M Bouvier
Journal:  Nat Rev Neurosci       Date:  2001-04       Impact factor: 34.870

Review 2.  Heterodimerization of G-protein-coupled receptors in the CNS.

Authors:  F H Marshall
Journal:  Curr Opin Pharmacol       Date:  2001-02       Impact factor: 5.547

3.  Spectral imaging and linear un-mixing enables improved FRET efficiency with a novel GFP2-YFP FRET pair.

Authors:  Timo Zimmermann; Jens Rietdorf; Andreas Girod; Virginie Georget; Rainer Pepperkok
Journal:  FEBS Lett       Date:  2002-11-06       Impact factor: 4.124

Review 4.  GPCR dimerisation.

Authors:  Graeme Milligan; Douglas Ramsay; Geraldine Pascal; Juan J Carrillo
Journal:  Life Sci       Date:  2003-12-05       Impact factor: 5.037

Review 5.  Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease.

Authors:  K Fuxe; L F Agnati; K Jacobsen; J Hillion; M Canals; M Torvinen; B Tinner-Staines; W Staines; D Rosin; A Terasmaa; P Popoli; G Leo; V Vergoni; C Lluis; F Ciruela; R Franco; S Ferré
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

6.  Regulation of heptaspanning-membrane-receptor function by dimerization and clustering.

Authors:  Rafael Franco; Meritxell Canals; Daniel Marcellino; Sergi Ferré; Luigi Agnati; Josefa Mallol; Vicent Casadó; Francisco Ciruela; Kjell Fuxe; Carmen Lluis; Enric I Canela
Journal:  Trends Biochem Sci       Date:  2003-05       Impact factor: 13.807

Review 7.  Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons.

Authors:  Luigi F Agnati; Sergi Ferré; Carme Lluis; Rafael Franco; Kjell Fuxe
Journal:  Pharmacol Rev       Date:  2003-07-17       Impact factor: 25.468

Review 8.  G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins.

Authors:  S S Ferguson; L S Barak; J Zhang; M G Caron
Journal:  Can J Physiol Pharmacol       Date:  1996-10       Impact factor: 2.273

9.  Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor.

Authors:  Maria Torvinen; Laura B Kozell; Kim A Neve; Luigi F Agnati; Kjell Fuxe
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer.

Authors:  Meritxell Canals; Daniel Marcellino; Francesca Fanelli; Francisco Ciruela; Piero de Benedetti; Steven R Goldberg; Kim Neve; Kjell Fuxe; Luigi F Agnati; Amina S Woods; Sergi Ferré; Carme Lluis; Michel Bouvier; Rafael Franco
Journal:  J Biol Chem       Date:  2003-08-21       Impact factor: 5.157

View more
  18 in total

1.  Adenosine A2A receptors in the nucleus accumbens bi-directionally alter cocaine seeking in rats.

Authors:  Casey E O'Neill; McKenzie L LeTendre; Ryan K Bachtell
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

Review 2.  GPCRs and Signal Transducers: Interaction Stoichiometry.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Pharmacol Sci       Date:  2018-05-05       Impact factor: 14.819

Review 3.  Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function.

Authors:  Kjell Fuxe; Sergi Ferré; Meritxell Canals; Maria Torvinen; Anton Terasmaa; Daniel Marcellino; Steven R Goldberg; William Staines; Kirsten X Jacobsen; Carmen Lluis; Amina S Woods; Luigi F Agnati; Rafael Franco
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 4.  Intramembrane receptor-receptor interactions: a novel principle in molecular medicine.

Authors:  K Fuxe; M Canals; M Torvinen; D Marcellino; A Terasmaa; S Genedani; G Leo; D Guidolin; Z Diaz-Cabiale; A Rivera; L Lundstrom; U Langel; J Narvaez; S Tanganelli; C Lluis; S Ferré; A Woods; R Franco; L F Agnati
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

Review 5.  Neurotransmitter receptor heteromers in neurodegenerative diseases and neural plasticity.

Authors:  Rafael Franco
Journal:  J Neural Transm (Vienna)       Date:  2008-11-11       Impact factor: 3.575

6.  Differential sensitivity of A2A and especially D2 receptor trafficking to cocaine compared with lipid rafts in cotransfected CHO cell lines. Novel actions of cocaine independent of the DA transporter.

Authors:  Susanna Genedani; Chiara Carone; Diego Guidolin; Monica Filaferro; Daniel Marcellino; Kjell Fuxe; Luigi Francesco Agnati
Journal:  J Mol Neurosci       Date:  2010-02-09       Impact factor: 3.444

Review 7.  Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.

Authors:  Ivone Gomes; Wakako Fujita; Moraje V Chandrakala; Lakshmi A Devi
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 8.  G Protein-Coupled Receptor Heteromers.

Authors:  Ivone Gomes; Mohammed Akli Ayoub; Wakako Fujita; Werner C Jaeger; Kevin D G Pfleger; Lakshmi A Devi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-22       Impact factor: 13.820

9.  Identification of two functionally distinct endosomal recycling pathways for dopamine D₂ receptor.

Authors:  Yun Li; Brittany D Roy; Wei Wang; Li Zhang; Lifeng Zhang; Stephen B Sampson; Yupeng Yang; Da-Ting Lin
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

10.  Stimulation of adenosine receptors in the nucleus accumbens reverses the expression of cocaine sensitization and cross-sensitization to dopamine D2 receptors in rats.

Authors:  Benjamin D Hobson; Kathryn E Merritt; Ryan K Bachtell
Journal:  Neuropharmacology       Date:  2012-06-28       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.